Financials
- Market Capitalization 19.51 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-30.87
ratio cours/chiffre d'affaires
0.74
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4633 | LGVN Longeveron Inc. - Class A Common stock | 0.63 USD | 0.00% | -3.08% | -23.17% | +10.27% | 19.62 M USD | ||
| 4634 | KALA KALA BIO, Inc. - Common Stock | 1.05 USD | -3.67% | -30.00% | -60.82% | -81.90% | 19.52 M USD | ||
| 4637 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.26 USD | -5.83% | -10.32% | -9.96% | +140.43% | 19.46 M USD | ||
| 4638 | LPCN Lipocine Inc. - Common Stock | 2.36 USD | +0.43% | -5.22% | +4.42% | -18.62% | 19.46 M USD |